Literature DB >> 16670633

Cytokines in necrotizing enterocolitis.

Troy A Markel1, Paul R Crisostomo, George M Wairiuko, Jeffrey Pitcher, Ben M Tsai, Daniel R Meldrum.   

Abstract

Necrotizing enterocolitis (NEC) is a devastating intra-abdominal emergency in the newborn period. The disease involves bowel wall inflammation, ischemic necrosis, eventual perforation, and the need for urgent surgical intervention. Unrecognized or left untreated, the neonate can decompensate quickly, often progressing to shock, multisystem organ failure, and eventual death. During the past several years, a number of basic science and clinical trials have been established in an attempt to understand the pathophysiology of NEC. As many researchers feel that NEC develops as an uncontrolled inflammatory response that leads to intestinal ischemia, a large number of studies have been focused on the inflammatory cascade and the role that cytokines play within that cascade. Although a large amount of data has been generated from these studies, the events leading to the ischemic injury of the intestine are still not fully understood. This article will therefore focus on the key cytokines involved with NEC, in an attempt to present the current literature and studies that support their involvement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670633     DOI: 10.1097/01.shk.0000192126.33823.87

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  44 in total

Review 1.  Toward improving mucosal barrier defenses: rhG-CSF plus IgG antibody.

Authors:  Aryeh Simmonds; Edmund F LaGamma
Journal:  Indian J Pediatr       Date:  2006-11       Impact factor: 1.967

Review 2.  Addressing the "New" NEC: Part I: rediscovering the basics.

Authors:  Aryeh Simmonds; Edmund F LaGamma
Journal:  Indian J Pediatr       Date:  2006-11       Impact factor: 1.967

3.  Early enteral stressors in newborns increase inflammatory cytokine expression in a neonatal necrotizing enterocolitis rat model.

Authors:  Rebecca Maria Rentea; Scott R Welak; Katherine Fredrich; Deborah Donohoe; Kirkwood A Pritchard; Keith T Oldham; David M Gourlay; Jennifer L Liedel
Journal:  Eur J Pediatr Surg       Date:  2012-11-19       Impact factor: 2.191

Review 4.  Intestinal microbiota and its relationship with necrotizing enterocolitis.

Authors:  Ravi Mangal Patel; Patricia W Denning
Journal:  Pediatr Res       Date:  2015-05-20       Impact factor: 3.756

5.  Protective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice.

Authors:  Francesca Saccani; Laura Anselmi; Ingrid Jaramillo; Simona Bertoni; Elisabetta Barocelli; Catia Sternini
Journal:  J Neurosci Res       Date:  2012-07-17       Impact factor: 4.164

6.  Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis.

Authors:  Catherine J Hunter; Monica Williams; Mikael Petrosyan; Yigit Guner; Rahul Mittal; Dennis Mock; Jeffrey S Upperman; Henri R Ford; Nemani V Prasadarao
Journal:  Infect Immun       Date:  2008-12-15       Impact factor: 3.441

Review 7.  The role of the intestinal microcirculation in necrotizing enterocolitis.

Authors:  Daniel J Watkins; Gail E Besner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

8.  Using a mathematical model to analyze the role of probiotics and inflammation in necrotizing enterocolitis.

Authors:  Julia C Arciero; G Bard Ermentrout; Jeffrey S Upperman; Yoram Vodovotz; Jonathan E Rubin
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

9.  Tumor necrosis factor-alpha and apoptosis signal-regulating kinase 1 control reactive oxygen species release, mitochondrial autophagy, and c-Jun N-terminal kinase/p38 phosphorylation during necrotizing enterocolitis.

Authors:  Naira Baregamian; Jun Song; C Eric Bailey; John Papaconstantinou; B Mark Evers; Dai H Chung
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

10.  Heparin-binding EGF-like growth factor is a potent dilator of terminal mesenteric arterioles.

Authors:  Yu Zhou; David Brigstock; Gail E Besner
Journal:  Microvasc Res       Date:  2009-04-21       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.